Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - BODISEN BIOTECH, INC | Financial_Report.xls |
| 10-K - BODISEN BIOTECH, INC. FORM 10-K - BODISEN BIOTECH, INC | form10k.htm |
| EX-31.1 - EXHIBIT 31.1 - BODISEN BIOTECH, INC | ex311.htm |
| EX-21.1 - EXHIBIT 21.1 - BODISEN BIOTECH, INC | ex211.htm |
| EX-31.2 - EXHIBIT 31.2 - BODISEN BIOTECH, INC | ex312.htm |
EXHIBIT 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Bo Chen, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report on Form 10-K of Bodisen Biotech, Inc. for the fiscal year ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Bodisen Biotech, Inc.
|
Dated: April 17, 2012
|
By:
|
/s/ Lin Wang
|
|
Lin Wang
|
||
|
Chief Executive Officer
|
I, Junyan Tong certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report on Form 10-K of Bodisen Biotech, Inc. for the fiscal year ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Bodisen Biotech, Inc.
|
Dated: April 17, 2012
|
By:
|
/s/ Junyan Tong
|
|
Junyan Tong
|
||
|
Chief Financial Officer
|